March 30, 2022 07:36 AM EDT
FDA+
Manufacturing

Biden like­ly to sign a bill that would crack down on Chi­na's choke­hold on the an­tibi­ot­ic sup­ply

Zachary Brennan

Senior Editor

The Sen­ate on Mon­day passed (68-28) a wide-rang­ing, Biden-backed and al­ready House-passed bill that would bol­ster Amer­i­can man­u­fac­tur­ing, and try to crack down on Chi­na’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times